Sonnet Biotherapeutics 获股东批准与 Hyperliquid Strategies Inc 进行业务合并
ChainCatcher 消息，据市场消息，纳斯达克上市生物科技公司 Sonnet Biotherapeutics 已获得股东批准，拟与 Hyperliquid Strategies Inc 进行业务合并。
此前消息，Hyperliquid Strategies 提交 S-1 文件，拟募资最高 10 亿美元或用于购入 HYPE 代币。
风险提示 风险提示
BTC $80,749.56 -1.21%
ETH $2,377.48 -0.98%
BNB $738.68 -0.27%
XRP $1.29 -2.45%
SOL $102.34 -1.81%
TRX $0.3297 +0.17%
DOGE $0.0785 -1.44%
ADA $0.2113 -2.37%
BCH $276.99 -3.60%
LINK $11.83 -2.89%
HYPE $76.95 -1.33%
AAVE $143.61 -3.70%
SUI $0.9598 -3.75%
XLM $0.1728 -3.04%
ZEC $1,169.46 -4.60%
AAPL $347.46 +0.20%
AMZN $248.82 -0.47%
GOOGL $321.79 -0.68%
MSFT $524.38 +1.52%
META $641.86 -0.39%
NVDA $211.41 -1.16%
TSLA $371.88 -1.13%
SNDK $1,240.45 -3.66%
INTC $86.71 -0.49%
SPCX $147.36 -0.52%
MU $883.82 +0.83%
AMD $518.04 +0.37% BTC $80,749.56 -1.21% ETH $2,377.48 -0.98% BNB $738.68 -0.27% XRP $1.29 -2.45% SOL $102.34 -1.81% TRX $0.3297 +0.17% DOGE $0.0785 -1.44% ADA $0.2113 -2.37% BCH $276.99 -3.60% LINK $11.83 -2.89% HYPE $76.95 -1.33% AAVE $143.61 -3.70% SUI $0.9598 -3.75% XLM $0.1728 -3.04% ZEC $1,169.46 -4.60% AAPL $347.46 +0.20% AMZN $248.82 -0.47% GOOGL $321.79 -0.68% MSFT $524.38 +1.52% META $641.86 -0.39% NVDA $211.41 -1.16% TSLA $371.88 -1.13% SNDK $1,240.45 -3.66% INTC $86.71 -0.49% SPCX $147.36 -0.52% MU $883.82 +0.83% AMD $518.04 +0.37%
风险提示 风险提示
ChainCatcher 与创新者共建Web3世界
